NasdaqCM - Nasdaq Real Time Price USD

EUDA Health Holdings Limited (EUDA)

3.4350

-0.1650

(-4.58%)

At close: 4:00:00 PM EDT

3.5400

+0.10

+(3.06%)

After hours: 4:05:41 PM EDT

EUDA Health Holdings Full Year 2024 Earnings: US$0.54 loss per share (vs US$0.37 loss in FY 2023)

EUDA Health Holdings ( NASDAQ:EUDA ) Full Year 2024 Results Key Financial Results Revenue: US$4.01m (up 8.2% from FY...

Simply Wall St. 27 days ago

EUDA
-4.58%

EUDAW
EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia

SINGAPORE, April 24, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based property management services provider and a leading non-invasive healthcare provider in Singapore and Malaysia, today announced an update to the potential strategic partnership, previously announced in December 2024, with Guangdong Cell Biotech Co. Ltd. (“Guangdong Cell Biotech”). Guangdong Cell Biotech is a prominent player in stem cell therapies and regenerativ

GlobeNewswire last month

EUDA
-4.58%

EUDAW
EUDA Health Holdings Limited (NASDAQ:EUDA) stock most popular amongst retail investors who own 49%, while private companies hold 27%

Key Insights The considerable ownership by retail investors in EUDA Health Holdings indicates that they collectively...

Simply Wall St. 4 months ago

EUDA
-4.58%

EUDAW
EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation

- Preliminary Discussions Underway to Establish a Joint Venture SINGAPORE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it has entered into preliminary discussions with Guangdong Cell Biotech Co. Ltd. (“Guangdong Cell Biotech”), a prominent player in stem cell therapies and regenerative medicin

GlobeNewswire 5 months ago

EUDA
-4.58%

EUDAW
NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule

MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces NRx Pharmaceuticals (NASDAQ: NRXP) will appear on the Emerging Growth Conference today in response to multiple requests and investor demand. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Jonathan Javitt, M

GlobeNewswire 6 months ago

CIA

BIXT

NRXBF
Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now

MIAMI, Oct. 30, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 76th Emerging Growth Conference on October 30 & 31, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting comp

GlobeNewswire 6 months ago

CIA

GOSS

STXPF
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 76th Emerging Growth Conference on October 30 & 31, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting comp

GlobeNewswire 6 months ago

VOXR

BVAXF

CIA
EUDA Health Holdings First Half 2024 Earnings: US$0.59 loss per share (vs US$0.40 loss in 1H 2023)

EUDA Health Holdings ( NASDAQ:EUDA ) First Half 2024 Results Key Financial Results Revenue: US$1.91m (down 32% from 1H...

Simply Wall St. 7 months ago

EUDA
-4.58%

EUDAW
Diamond Equity Research Initiates Coverage on EUDA Health Holdings Limited (NASDAQ:EUDA)

New York, NY, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of EUDA Health Holdings Ltd. (NASDAQ: EUDA). The in-depth 30-page initiation report includes detailed information on the EUDA’s business model, services, industry overview, valuation, management profile, and risks. The full research report is available here. EUDA Health Holdings Ltd. Initiation of Coverage Highlights

GlobeNewswire 8 months ago

EUDA
-4.58%

EUDAW
Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

MIAMI, Aug. 20, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 74th Emerging Growth Conference on August 21 – 22, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compa

GlobeNewswire 9 months ago

BIDCF

PCYO

SIGY
Retail investors are EUDA Health Holdings Limited's (NASDAQ:EUDA) biggest owners and were hit after market cap dropped US$16m

Key Insights The considerable ownership by retail investors in EUDA Health Holdings indicates that they collectively...

Simply Wall St. 9 months ago

EUDA
-4.58%

EUDAW

Performance Overview

Return	EUDA	S&P 500 (^GSPC)
YTD	-23.24%	+0.52%
1-Year	+29.62%	+12.25%
3-Year	-65.09%	+42.18%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

EUDA Health Holdings Limited (EUDA)

EUDA Health Holdings Full Year 2024 Earnings: US$0.54 loss per share (vs US$0.37 loss in FY 2023)

EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia

EUDA Health Holdings Limited (NASDAQ:EUDA) stock most popular amongst retail investors who own 49%, while private companies hold 27%

EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation

NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule

Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

EUDA Health Holdings First Half 2024 Earnings: US$0.59 loss per share (vs US$0.40 loss in 1H 2023)

Diamond Equity Research Initiates Coverage on EUDA Health Holdings Limited (NASDAQ:EUDA)

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Retail investors are EUDA Health Holdings Limited's (NASDAQ:EUDA) biggest owners and were hit after market cap dropped US$16m

Performance Overview